Depsipeptide (FK228) preferentially induces apoptosis in BCR/ABL-expressing cell lines and cells from patients with chronic myelogenous leukemia in blast crisis
- PMID: 17610380
- DOI: 10.1089/scd.2007.9994
Depsipeptide (FK228) preferentially induces apoptosis in BCR/ABL-expressing cell lines and cells from patients with chronic myelogenous leukemia in blast crisis
Abstract
Resistance to imatinib can occur in patients with chronic myelogenous leukemia (CML). In this study, we report mechanisms of action of histone deacetylase (HDAC) inhibitor, depsipeptide (FK228) in BCR/ABL-expressing cell lines and its effectiveness in imatinib-resistant cells from patients with blast crisis of CML. FK228 potently induced apoptosis of TF-1 BCR/ABL, K562, and H7 BCR/ABL cells. We found that histone H4, BCR/ABL, heat shock protein 90 (HSP-90), p53, focal adhesion kinase (FAK), paxillin, and retinoblastoma protein (Rb) were acetylated in the treated cells. Cells were also blocked in G(2)/M phase of the cell cycle and activity of mitogen-activated protein kinase (MAPK) was blocked, but p38MAPK (p38) was activated. Inhibitor of apoptosis proteins (IAPs) were suppressed, and common results of apoptotic induction were observed, such as caspase-3, caspase-9, and poly(ADP-ribose) polymerase (PARP) activation. Although p38 was phosphorylated after FK228 treatment, histone H4 acetylation, caspase-3 activation, and apoptosis were not inhibited by treatment with the p38 inhibitor SB203580. We also found that human telomerase reverse transcriptase (hTERT) ShRNA-transfected cells demonstrated decreased FK228-induced apoptosis. Of clinical relevance, FK228-induced apoptosis of imatinib-resistant primary cells from patients with CML, who had progressed to blast crisis (BC) while receiving therapy with imatinib. In conclusion, FK228 potently induces apoptosis of CML cells by acetylation and degradation of BCR/ABL protein. Our study suggests how FK228 may mediate its effects on imatinib-resistant CML cells.
Similar articles
-
Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells.Cancer Res. 2003 Aug 15;63(16):5126-35. Cancer Res. 2003. PMID: 12941844
-
Triptolide induces cell death independent of cellular responses to imatinib in blast crisis chronic myelogenous leukemia cells including quiescent CD34+ primitive progenitor cells.Mol Cancer Ther. 2009 Sep;8(9):2509-16. doi: 10.1158/1535-7163.MCT-09-0386. Epub 2009 Sep 1. Mol Cancer Ther. 2009. PMID: 19723894 Free PMC article.
-
Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3.Blood. 2005 Feb 15;105(4):1768-76. doi: 10.1182/blood-2004-09-3413. Epub 2004 Oct 28. Blood. 2005. PMID: 15514006
-
[Research advance on molecular genetics of CML blast crisis].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb;16(1):217-21. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008. PMID: 18315935 Review. Chinese.
-
Characterization of cancer stem cells in chronic myeloid leukaemia.Biochem Soc Trans. 2007 Nov;35(Pt 5):1347-51. doi: 10.1042/BST0351347. Biochem Soc Trans. 2007. PMID: 17956348 Review.
Cited by
-
Epigenetic regulation of the human telomerase reverse transciptase gene: A potential therapeutic target for the treatment of leukemia (Review).Oncol Lett. 2013 Aug;6(2):317-322. doi: 10.3892/ol.2013.1367. Epub 2013 May 29. Oncol Lett. 2013. PMID: 24137323 Free PMC article.
-
HDAC inhibitor PAC-320 induces G2/M cell cycle arrest and apoptosis in human prostate cancer.Oncotarget. 2017 Dec 8;9(1):512-523. doi: 10.18632/oncotarget.23070. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416632 Free PMC article.
-
Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death.J Biol Chem. 2011 Sep 2;286(35):30937-30948. doi: 10.1074/jbc.M110.212035. Epub 2011 Jul 8. J Biol Chem. 2011. PMID: 21757750 Free PMC article.
-
Histone demethylase RBP2 decreases miR-21 in blast crisis of chronic myeloid leukemia.Oncotarget. 2015 Jan 20;6(2):1249-61. doi: 10.18632/oncotarget.2859. Oncotarget. 2015. PMID: 25575817 Free PMC article.
-
Regulatory Molecules and Corresponding Processes of BCR-ABL Protein Degradation.J Cancer. 2019 Jun 2;10(11):2488-2500. doi: 10.7150/jca.29528. eCollection 2019. J Cancer. 2019. PMID: 31258755 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous